Loading
Latest filing published 01 Apr 2025 for Genmab A/S.
No signal scores available.
This profile gathers the share dealings of Elizabeth O’Farrell in Genmab A/S. In total, 2 filings cover trades dated from 29 March 2022 to 1 April 2025.
Not one of the filings records a straightforward purchase or sale on the market. Such operations are usually part of compensation schedules, which makes them a weaker signal than an open-market trade.
The newest entry dates from 1 April 2025: a transaction, in Genmab A/S. These figures are compiled from regulatory filings published by Finanstilsynet DK. They describe what insiders did and are not a recommendation.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
2 of 2 declarations